Transgenic and therapeutic targeting of smooth muscle cells and the challenges presented by phenotypic diversity

Bibliography

• OLSON EN, KLEIN WH: bHLH Factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. (1994) 8:1–8.
   PubMed Web of Science ®Google Scholar
• OWENS GK: Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. (1995) 75:487–517.
   PubMed Web of Science ®Google Scholar
• BLACK BL, OLSON EN: Transcriptional control of muscle development by myocyte enhancer factor-2(MEF2) proteins. Annu. Rev. Cell Dev. Biol. (1998) 14:167–196.
   PubMed Web of Science ®Google Scholar
• BUCKINGHAM M: Molecular biology of muscle develop-ment. Cell (1994) 78:15–21.
   PubMed Web of Science ®Google Scholar
• JAMES J, ROBBINS J: Molecular remodeling of cardiac contractile function. Am. J. Physic]. Heart Circ. Physiol. (1997) 273:H2105–H2118.
   Web of Science ®Google Scholar
• ••See annotation for reference 6.
   Google Scholar
• JAMES JF, HEWETT TE, ROBBINS J: Cardiac physiology in transgenic mice. Circ. Res. (1998) 82:407–415.
   PubMed Web of Science ®Google Scholar
• ••Comprehensive reviews of cardiac transgenesis, develop-ment, anatomy and physiology in the mouse.
   Google Scholar
• VON ARX P, BANTLE S, SOLDATI T, PERRIARD JC: Dominant negative effect of cytoplasmic actin isopro-teins on cardiomyocyte cytoarchitecture and function. J. Cell Biol. (1995) 131:1759.
   PubMed Web of Science ®Google Scholar
• ••Interesting report describing the effects of non-homologousactin isoforms on cardiomyocyte structure and function.
   Google Scholar
• DeN0FRIO D, HOOCK TC, HERMAN IM: Functionalsorting of actin isoforms in microvascular pericytes. Cell Biol. (1989) 109:191–202.
   PubMed Web of Science ®Google Scholar
• QU G, YAN H, STRAUCH AR: Actin isoform utilizationduring differentiation and remodeling of BC3H1 myogenic cells. J. Cell. Biochem. (1997) 67:514–527.
   PubMed Web of Science ®Google Scholar
• RONNOV-JESSEN L, PETERSEN OW: A function for filamentous a-smooth muscle actin: retardation of motility in fibroblasts. J. Cell Biol. (1996) 134:67–80.
   PubMed Web of Science ®Google Scholar
• HILL MA, GUNNING P: Beta and gamma actin mRNAsare differentially located within myoblasts. J. Cell Biol. (1993) 122:825–832.
   PubMed Web of Science ®Google Scholar
• LLOYD C, SCHEVZOV G, GUNNING P: Transfection of non-muscle 13-and gamma-actin genes into myoblasts elicits different feedback regulatory responses from endogenous actin genes. J. Cell Biol. (1992) 117:787–797.
   PubMed Web of Science ®Google Scholar
• SCHEVZOV G, LLOYD C, GUNNING P: High level expres-sion of transfected 13-and gamma-actin genes differen-tially impacts on myoblast cytoarchitecture. J. Cell Biol. (1992) 117:775–785.
   PubMed Web of Science ®Google Scholar
• STROMER MH: Immunocytochemistry of the muscle cell cytoskeleton. Microsc. Res. Tech. (1995) 31:95–105.
   PubMed Web of Science ®Google Scholar
• MURPHY RA: Special topic: contraction in smooth muscle cells. Introduction. Annu. Rev. Physiol. (1989) 51:275–283.
   PubMed Web of Science ®Google Scholar
• SOMLYO AP: Myosin isoforms in smooth muscle: howmay they affect function and structure. J. Muscle Res. Cell Motil. (1993) 14:557–563.
   PubMed Web of Science ®Google Scholar
• HATHAWAY DR, MARCH KL, LASH JA, ADAM LP, WILENSKY RL: Vascular smooth muscle: a review of the molecular basis of contractility. Circulation (1991) 83:382–390.
   PubMed Web of Science ®Google Scholar
• KURIYAMA H, KITAMURA K, ITOH T, INOUE R: Physio-logical features of visceral smooth muscle cells, with special reference to receptors and ion channels. Physiol. Rev. (1998) 78:811–920.
   PubMed Web of Science ®Google Scholar
• STRAUCH AR, BERMAN MD, MILLER HR: Substrate-associated macromolecules promote cytodifferentia-tion of BC3H1 myogenic cells. J. Cell. Physiol. (1991) 146:337–348.
   PubMed Web of Science ®Google Scholar
• LEE SH, YAN H, REESER JC, DILLMAN JM, STRAUCH AR:Proteoglycan biosynthesis is required in BC3H1 myogenic cells for modulation of vascular smooth muscle a-actin gene expression in response to microenvironmental signals. J. Cell. Physiol. (1995) 164:172–186.
   PubMed Web of Science ®Google Scholar
• CLOWES AW, CLOWES MM, KOCHER O et al. Arterial smooth muscle cells in vivo: relationship between actin isoform expression and mitogenesis and their modulation by heparin. J. Cell Biol. (1988) 107:1939–1945.
   PubMed Web of Science ®Google Scholar
• ••First report of functional modulation of smooth muscle actinmRNA expression in vivo.
   Google Scholar
• LIAU G, JANAT MF, WIRTH PJ: Regulation of a-smoothmuscle actin and other polypeptides in proliferating and density-arrested vascular smooth muscle cells. J. Cell. Physic)]. (1990) 142:236–246.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ SM, REIDY MA: Common mechanisms ofproliferation of smooth muscle in atherosclerosis and hypertension. Human Pathol. (1987) 18:240–247.
   PubMed Web of Science ®Google Scholar
• SKALLI O, PELTE MF, PECLET MC et al. a-Smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. Histochem. Cytochem. (1989) 37:315–321.
   PubMed Web of Science ®Google Scholar
• KOCHER O, GABBIANI G: Analysis of a-smooth-muscle actin mRNA expression in rat aortic smooth-muscle cells using a specific cDNA probe. Differentiation (1987) 34:201–209.
   PubMed Web of Science ®Google Scholar
• KOCHER O, GABBIANI F, GABBIANI G et al. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab. Invest. (1991) 65:459–470.
   PubMed Web of Science ®Google Scholar
• ••Evaluation of smooth muscle actin mRNA levels in vascularlesions.
   Google Scholar
• KAUFMAN MH: The Atlas of Mouse Development. AcademicPress, London, UK (1992).
   Google Scholar
• MCHUGH KM, CRAWFORD K, LESSARD JL: A comprehen-sive analysis of developmental and tissue-specific expression of the isoactin multigene family in the rat. Dev. Biol. (1991) 148:442–458.
   PubMed Web of Science ®Google Scholar
• •Detailed analysis of actin isoform mRNA levels in the developing rat embryo.
   Google Scholar
• ROSS R: Atherosclerosis: a defense mechanism gone awry. Am. J. Pathol. (1993) 143:987–1002.
   PubMed Web of Science ®Google Scholar
• ROSS R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 362:801–809.
   PubMed Web of Science ®Google Scholar
• BORNFELDT KE, GRAVES LM, RAINES EW et al. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J. Cell Biol. (1995) 130:193–206.
   PubMed Web of Science ®Google Scholar
• SKALLI O, GABBIANI G: The biology of the myofibro-blast. Relation to wound contraction and fibrocontrac-tive diseases. In: The Molecular and Cellular Biology of Wound Repair. Clark RAF, Henson PM (Eds.), Plenum Publishing Corp. New York, USA (1988):373–401.
   Google Scholar
• ••An important, authoritative review of myofibroblast cellbiology.
   Google Scholar
• KULLO I, SIMARI RD, SCHWARTZ RS: Vascular gene transfer. From bench to bedside. Arterioscler. Thromb. Vasc. Biol. (1999) 19:196–207.
   PubMed Web of Science ®Google Scholar
• CAREY DJ: Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu. Rev. Physiol. (1991) 53:161-177. 35.Receptors for Extracellular Matrix. McDonald JA, Mecham RP (Eds.), Academic Press, Inc., San Diego, USA (1991).
   PubMed Web of Science ®Google Scholar
• MECHAM RP, WHITEHOUSE LA, WRENN DS et al. Smooth muscle-mediated connective tissue remodelling in pulmonary hypertension. Science (1987) 237:423–426.
   PubMed Web of Science ®Google Scholar
• •Report showing that smooth muscle cells release soluble mediators of elastin gene expression.
   Google Scholar
• CHEN Y, BORNFELDT KE, ARNER A et al. Increase in insulin-like growth Factor I in hypertrophying smooth muscle. Am. J. Physiol. (1994) 266:E224–229.
   Web of Science ®Google Scholar
• SCHWARTZ SM, DEBLOIS D, O'BRIEN ERM: The intima-soil for atherosclerosis and restenosis. Circ. Res. (1995) 77:445–465.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ SM: Smooth muscle migration in athero-sclerosis and restenosis. J. Clin. Invest. (1997) 99:2814–2817.
   PubMed Web of Science ®Google Scholar
• •An interesting overview of cell proliferation-independent aspects of arteriosclerosis.
   Google Scholar
• HERMAN IM: Actin isoforms. Curr. Opin. Cell Biol. (1993) 5:48.
   PubMed Web of Science ®Google Scholar
• DE RUITER MC, POELMANN RE, VAN MUNSTEREN JC et al. Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actin in vivo and in vitro. Circ. Res. (1997) 80:444–451.
   Google Scholar
• ••Injury-activation of endothelial cells can promote expres-sion of smooth muscle-specific actin.
   Google Scholar
• ABD-EL BASSET E, FEDEROFT S: Immunolocalization of the alpha isoform of smooth muscle actin in mouse astroglia in cultures. Neuroscience Lett. (1991) 125:117–120.
   PubMed Web of Science ®Google Scholar
• LECAIN E, ALLIOT F, LAINE B, CALAS B, PESSAC B: Alphaisoform of smooth muscle actin is expressed in astrocytes in vitro and in vivo. J. Neuroscience Res. (1991) 28:601–606.
   PubMed Web of Science ®Google Scholar
• HIRSCHI KK, D'AMORE PA: Pericytes in the microvascu-lature. Cardiovasc. Res. (1996) 32:687–698.
   PubMed Web of Science ®Google Scholar
• HIRSCHI KK, ROHOVSKY SA, D'AMORE PA: PDGF, TGF-I3, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. (1998) 141:805–814.
   PubMed Web of Science ®Google Scholar
• COGAN JG, SUN S, STOFLET ES et al. Plasticity of vascular smooth muscle a-actin gene transcription. Characterization of multiple, single-, and double-strand specific DNA-binding proteins in myoblasts and fibroblasts. J. Biol. Chem. (1995) 270:11310–11321.
   PubMed Web of Science ®Google Scholar
• ••See annotation for reference 47.
   Google Scholar
• SUN S, STOFLET ES, COGAN JG, STRAUCH AR, GETZ MJ: Negative regulation of the vascular smooth muscle a-actin gene in fibroblasts and myoblasts: disruption of enhancer function by sequence-specific single-stranded-DNA-binding proteins. Molec. Cell. Biol. (1995) 15:2429–2436.
   PubMed Web of Science ®Google Scholar
• ••First reports of the involvement of TEF1, MSY1, andPURa/PURO in regulation of the mouse smooth muscle a-actin gene.
   Google Scholar
• HAUTMANN MB, MADSEN CS, MACK CP, OWENS GK: Substitution of the degenerate smooth muscle (SM) a-actin CC(A/T-rich)6GG elements with c-fos serum response elements results in increased basal expres-sion but relaxed SM cell specificity and reduced angiotensin II inducibility. J. Biol. Chem. (1998) 273:8398–8406.
   PubMed Web of Science ®Google Scholar
• SWARTZ EA, JOHNSON AD, OWENS GK: Two MCAT elements of the SM a-actin promoter function differ-entially in SM vs. non-SM cells. Am. J. Physiol. Cell Physiol. (1998) 275:C608–C618.
   Web of Science ®Google Scholar
• KELM RJ, JR., ELDER PK, STRAUCH AR, GETZ MJ:Sequence of cDNAs encoding components of vascular actin single-stranded DNA-binding factor 2 establish identity to Pura and Pur 13. J. Biol. Chem. (1997) 272:26727–26733.
   PubMed Web of Science ®Google Scholar
• HANAHAN D: Signaling vascular morphogenesis andmaintenance. Science (1997) 277:48–50.
   PubMed Web of Science ®Google Scholar
• •Useful review of tyrosine receptor kinases, angiopoietins, and vasculogenesis.
   Google Scholar
• CARMELIET P, COLLEN D: Genetic analysis of bloodvessel formation-role of endothelial versus smooth muscle cells. Trends Cardiovasc. Med. (1997) 7:271–281.
   PubMed Web of Science ®Google Scholar
• CARMELIET P, COLLEN D: Molecular analysis of bloodvessel formation and disease. Am. J. Physiol. Heart Circ. Physiol. (1997) 273:H2091–H2104.
   Web of Science ®Google Scholar
• FOLKMAN J, D'AMORE PA: Blood vessel formation: whatis its molecular basis? Cell (1996) 87:1153–1155.
   PubMed Web of Science ®Google Scholar
• •Concise overview of data and presentation of a model for endothelial cell-mesenchymal cell interactions during vasculogenesis.
   Google Scholar
• BECK L, JR., D'AMORE PA: Vascular development:cellular and molecular regulation. FASEB J. (1997) 11:365–373.
   PubMed Web of Science ®Google Scholar
• BERGWERFF M, VERBERNE ME, DE RUITER MC, POELMANN RE, GITTENBERGER-DE GROOT AC: Neural crest contribution to the developing circulatory system. Implications for vascular morphology? Circ. Res. (1998) 82:221–231.
   Google Scholar
• ••See annotation for reference 59.
   Google Scholar
• MIKAWA T: Retroviral targeting of FGF and FGFR in cardiomyocytes and coronary vascular cells during heart development. Ann. NY Acad. Sci. (1995) 752:506–515.
   PubMed Web of Science ®Google Scholar
• ••See annotation for reference 59.
   Google Scholar
• MIKAWA T, GOURDIE RG: Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with in-growth of the epicardial organ. Dev. Biol. (1996) 174:221-232.
   Google Scholar
• ••See annotation for reference 59.
   Google Scholar
• MIKAWA T, FISCHMAN DA: Retroviral analysis of cardiac morphogenesis: discontinuous formation of coronary vessels. Proc. Natl. Acad. Sci. USA (1992) 89:9504–9508.
   Google Scholar
• ••Four studies that utilise retroviral tagging techniques to trackthe fates of vascular and myocardial progenitor cells in developing avian embryos.
   Google Scholar
• FRID MG, ALDASHEV AA, DEMPSEY EC, STENMARK KR:Smooth muscle cells isolated from discrete compart-ments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities. Circ. Res. (1997) 81:940–952.
   PubMed Web of Science ®Google Scholar
• GADSON PF, ROSSIGNOL C, MCCOY J, ROSENQUIST TH:Expression of elastin, smooth muscle alpha-actin, and c-jun as a function of the embryonic lineage of vascular smooth muscle cells. In vitro Cell. Dev. Biol. (1993) 26A:773–781.
   Google Scholar
• ROSS R: The pathogenesis of atherosclerosis-anupdate. New Engl. J. Med. (1986) 314:488–500.
   PubMed Web of Science ®Google Scholar
• ARMSTRONG AT, STRAUCH AR, STARLING RC, SEDMAK DD, OROSZ CG: Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation (1997) 63:941–947.
   PubMed Web of Science ®Google Scholar
• ••See annotation for reference 64.
   Google Scholar
• ARMSTRONG AT, STRAUCH AR, STARLING RC, SEDMAK DD, OROSZ CG: Morphometric analysis of neointimal formation in murine cardiac allografts. II. Rate and location of lesion formation. Transplantation (1997) 64:322–328.
   PubMed Web of Science ®Google Scholar
• ••First reports of discontinuous coronary artery lesionformation in the transplanted murine heart.
   Google Scholar
• MIKAWA T: Cardiac lineages. In: Heart Development.Harvey RP, Rosenthal N (Eds.), Academic Press, San Diego, USA (1999):19–33.
   Google Scholar
• KIM S, IP HS, LU MM, CLENDENIN C, PARMACEK MS: A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Molec. Cell. Biol. (1997) 17:2266–2278.
   PubMed Web of Science ®Google Scholar
• ••One of the first reports to identify transcriptional regulatoryelements in the SM22a promoter using transgenic mouse models.
   Google Scholar
• LENZ J, OKENGUIST S, LOSARDO J, HAMILTON K, DOETSCH P: Identification of a mammalian nuclear factor and human cDNA encoded proteins that recognize DNA containing multiple apurinic sites. Proc. Natl. Acad. Sci. USA (1990) 87:3396–3400.
   PubMed Web of Science ®Google Scholar
• CLEAVER O, KRIEG PA: Molecular mechanisms of vascular development. In: Heart Development. Harvey RP, Rosenthal N (Eds.) Academic Press, San Diego, USA (1999):221–252.
   Google Scholar
• ••Comprehensive overview of molecular signalling duringarterial development.
   Google Scholar
• SURI C, JONES PF, PATAN S et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, duringembryonic angiogenesis. Cell (1996) 87:1171–1180.
   PubMed Web of Science ®Google Scholar
• ••Important paper describing the failure of angiopoietin 1knock-out mice to recruit smooth muscle and pericyte progenitor cells during vasculogenesis.
   Google Scholar
• SCHATTEMAN G, MOTLEY ST, EFFMANN EL, BOWEN-POPE DF: Platelet-derived growth factor receptor alpha subunit deleted patch mouse exhibits severe cardiovascular dysmorphogenesis. Teratology (1995) 51:351–366.
   PubMedGoogle Scholar
• BOSTRUM H, WILLETTS K, PEKNY P et al. PDGF-Asignaling is a critcal event in lung alveolar myofibro-blast development and alveogenesis. Cell (1996) 85:863–873.
   PubMed Web of Science ®Google Scholar
• SHI CW, RUSSELL ME, BIANCHI C, NEWELL JB, HABER E: Murine model of accelerated transplant arterioscle-rosis. Circ. Res. (1994) 75:199–207.
   PubMed Web of Science ®Google Scholar
• ••One of the first reports to utilise immune-compromised, transgenic mouse lines as recipients in organ transplant studies.
   Google Scholar
• SOLWAY J, SELTZER J, SAMAHA FF et al. Structure and expression of a smooth muscle cell-specific gene, SM22a. J. Biol. Chem. (1995) 270:13460–13469.
   PubMed Web of Science ®Google Scholar
• ••First functional study of SM22a cDNA and genomicsequences in smooth muscle tissues and transfected cells.
   Google Scholar
• FIRULLI AB, MIANO JM, BI WZ et al. Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells-association with the activated phenotype. Circ. Res. (1996) 78:196–204.
   PubMed Web of Science ®Google Scholar
• ZALEWSKI A, SHI Y: Vascular myofibroblasts-lessons from coronary repair and remodeling. Arterioscler. Thromb. Vasc. Biol. (1997) 17:417–422.
   PubMed Web of Science ®Google Scholar
• •See annotation for reference 77.
   Google Scholar
• PELS K, LABINAZ M, HOFFERT C, O'BRIEN ER: Adventitial angiogensis early after coronary angioplasty. Correla-tion with arterial remodeling. Arterioscler. Thromb. Vasc. Biol. (1999) 19:229–238.
   PubMed Web of Science ®Google Scholar
• •See annotation for reference 77.
   Google Scholar
• TJURMIN AV, ANANYEVA NM, SMITH EP et al. Studies on the histogenesis of myxomatous tissue of human coronary lesions. Arterioscler. Thromb. Vasc. Biol. (1999) 19:83–97.
   PubMed Web of Science ®Google Scholar
• •Three reports describing new roles for smooth muscle-like stromal cells in arterial injury and repair.
   Google Scholar
• GALMICHE MC, KOTELIANSKY VE, BRIERE J, HERVE P, CHARBORD P: Stromal cells from human long-term marrow cultures are mesenchymal cells that differen-tiate following a vascular smooth muscle differentia-tion pathway. Blood (1993) 82:66–76.
   PubMed Web of Science ®Google Scholar
• MURRY CE, GIPAYA CT, BARTOSEK T, BENDITT EP, SCHVVARTZ SM: Monoclonality of smooth muscle cells in human atherosclerosis. Am. J. Pathol (1997) 151:697–706.
   PubMed Web of Science ®Google Scholar
• •Recent evidence to support Benditt's monoclonal theory of atherogenesis in the human.
   Google Scholar
• OLSON EN, CALDWELL KC, GORDON JI, GLASER L: Regulation of creatine phosphokinase expression during differentiation of BC3H1 cells. J. Biol. Chem. (1983) 258:2644–2652.
   PubMed Web of Science ®Google Scholar
• ARMSTRONG AT, STRAUCH AR, STARLING RC, SEDMAKDD, OROSZ CG: Morphometric analysis of neointimal formation in murine cardiac grafts. III. Dissociation of interstitial fibrosis from neointimal formation. Transplantation (1997) 64:1198–1202.
   PubMed Web of Science ®Google Scholar
• TUCZU EM, DEFRANCO AC, GOORMASTIC MEA: Dichotomous pattern of coronary arteriosclerosis 1 to 9 years after transplantation: insights from systematic intravascular ultrasound imaging. J. Am. Coll. Cardiol (1996) 27:839.
   PubMed Web of Science ®Google Scholar
• SHANAHAN CM, WEISSBERG PL: Smooth muscle cell heterogeneity-patterns of gene expression in vascular smooth muscle cells in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. (1998) 18:333–338.
   PubMed Web of Science ®Google Scholar
• MCHUGH KM: Molecular analysis of smooth muscledevelopment in the mouse. Dev. Dyn. (1995) 204:278–290.
   PubMed Web of Science ®Google Scholar
• RUZICKA DL, SCHWARTZ RJ: Sequential activation ofa-actin genes during avian cardiogenesis: vascular smooth muscle a-actin gene transcripts mark onset of cardiomyocyte differentiation. J. Cell Biol. (1988) 107:2575–2586.
   PubMed Web of Science ®Google Scholar
• •First report to document smooth muscle actin expression during avian cardiogenesis.
   Google Scholar
• HAUTMANN MB, THOMPSON MM, SWARTZ EA, OLSON EN, OWENS GK: Angiotensin 11-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox. Circ. Res. (1997) 81:600–610.
   PubMed Web of Science ®Google Scholar
• HAUTMANN MB, MADSEN CS, OWENS GK: A transforming growth factor 3 (TGF6) control element drives TGF6-induced stimulation of smooth muscle a-actin gene expression in concert with two CArG elements. J. Biol. Chem. (1997) 272:10948–10956.
   PubMed Web of Science ®Google Scholar
• STRAUCH AR, COGAN JG, SUBRAMANIAN SV et al. Transcriptional activity of the vascular smooth muscle alpha-actin gene as an indicator of cellular injury following cardiac transplant. Transplant Immunol (1997) 5:1–6.
   Web of Science ®Google Scholar
• MIN B, FOSTER DN, STRAUCH AR: The 5'-flanking region of the mouse vascular smooth muscle a-actin gene contains evolutionarily conserved sequence motifs within a functional promoter. J. Biol. Chem. (1990) 265:16667–16675.
   PubMed Web of Science ®Google Scholar
• ••See annotation for reference 91.
   Google Scholar
• FOSTER DN, MIN B, FOSTER LK et al. Positive and negative cis-acting regulatory elements mediate expression of the mouse vascular smooth muscle a-actin gene. J. Biol. Chem. (1992) 267:11995–12003.
   PubMed Web of Science ®Google Scholar
• ••See annotation for reference 91.
   Google Scholar
• STOFLET ES, SCHMIDT LJ, ELDER PK et al. Activation of a muscle-specific actin gene promoter in serum-stimulated fibroblasts. Molec. Biol. Cell (1992) 3:1073–1083.
   PubMed Web of Science ®Google Scholar
• ••First reports to describe the sequence and functional proper-ties of the mouse smooth muscle a-actin promoter.
   Google Scholar
• WANG JW, NIU W, NIKIFOROV Y et al: Targeted overex-pression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J. Clin. Invest. (1997) 100:1425–1439.
   PubMed Web of Science ®Google Scholar
• ••See annotation for reference 93.
   Google Scholar
• WANG JW, NIU W, WITTE DP et al. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle a-actin-IMP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology (1998) 139:2605–2614.
   PubMed Web of Science ®Google Scholar
• ••The first two reports to describe tissue specific targeting ofexogenous cDNAs to smooth muscle beds in transgenic mice using the SMP8 VSM a-actin targeting promoter.
   Google Scholar
• SAWTELL NM, LESSARD JL: Cellular distribution of smooth muscle actins during mammalian embryo-genesis: expression of the a-vascular but not the gamma-enteric isoform in differentiating striated myocytes. J. Cell Biol. (1989) 109:2929–2937.
   PubMed Web of Science ®Google Scholar
• SHIMIZU RT, BLANK RS, JERVIS R, LAWRENZ-SMITH Sc, OWENS GK: The smooth muscle a-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells. J. Biol. Chem. (1995) 270:7631–7643.
   PubMed Web of Science ®Google Scholar
• BROWNING CL, CULBERSON DE, ARAGON IV et al. Thedevelopmentally regulated expression of serum response factor plays a key role in the control of smooth muscle-specific genes. Dev. Biol. (1998) 194:18–37.
   PubMed Web of Science ®Google Scholar
• CHEN CY, CROISSANT J, MAJESKY M et al. Activation ofthe cardiac a-actin promoter depends upon serum response factor, tinman homologue, Nkx-2.5, and intact serum response elements. Dev. Genet. (1996) 19:119–130.
   PubMedGoogle Scholar
• CROISSANT JD, KIM JH, EICHELE G et al. Avian serum response factor expression restricted primarily to muscle cell lineages is required for a-actin gene transcription. Dev. Biol. (1996) 177:250–264.
   PubMed Web of Science ®Google Scholar
• PARADIS P, MACLELLAN WR, BELAGULI NS, SCHWARTZ RJ, SCHNEIDER MD: Serum response factor mediates AP-1-dependent induction of the skelet al a-actin promoter in ventricular myocytes. J. Biol. Chem. (1996) 271:10827–10833.
   PubMed Web of Science ®Google Scholar
• MACLELLAN WR, LEE TC, SCHWARTZ RJ, SCHNEIDER MD: Transforming growth factor-8 response elements of the skelet al a-actin gene. Combinatorial action of serum response factor, YY1, and the 5V40 enhancer-binding protein, TEF-1. J. Biol. Chem. (1994) 269:16754–16760.
   PubMed Web of Science ®Google Scholar
• LEE TC, CHOW KL, FANG P, SCHWARTZ RJ: Activation of skelet al a-actin gene transcription: the co-operative formation of serum response factor-binding complexes over positive cis-acting promoter serum response elements displaces a negative-acting nuclear factor enriched in replicating myoblasts and non-myogenic cells. Mol. Cell. Biol. (1991) 11:5090–5100.
   PubMed Web of Science ®Google Scholar
• TREISMAN R: Identification and purification of a polypeptide that binds to the c-fos serum response element. EMBO J (1987) 6:2711–2717.
   PubMed Web of Science ®Google Scholar
• PRYWES R, ROEDER RG: Purification of the c-fos enhancer-binding protein. Ma Cell. Biol. (1987) 7:3482–3489.
   Web of Science ®Google Scholar
• MADSEN CS, REGAN CP, OWENS GK: Interaction of CArG elements and a GC-rich repressor element in transcriptional regulation of the smooth muscle myosin heavy chain gene in vascular smooth muscle cells. J. Biol. Chem. (1997) 272:29842–29851.
   PubMed Web of Science ®Google Scholar
• MACK CP, OWENS GK: Regulation of smooth muscle a-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. Circ. Res. (1999) 84:852–861.
   PubMed Web of Science ®Google Scholar
• •Transgenic analysis of CARG element function in the smooth muscle actin promoter.
   Google Scholar
• STRAUCH AR, RUBENSTEIN PA: Induction of vascular smooth muscle a-isoactin expression in BC3H1 cells. J. Biol. Chem. (1984) 259:3152–3159.
   PubMed Web of Science ®Google Scholar
• STRAUCH AR, REESER JC: Sequential expression of smooth muscle and sarcomeric a-actin isoforms during BC3H1 cell differentiation. J. Biol. Chem. (1989) 264:8345–8355.
   PubMed Web of Science ®Google Scholar
• DESMOULIERE A, GABBIANI G: The role of myofibro-blasts in wound healing and fibrocontractile diseases. In: The Molecular and Cellular Biology of Wound Repair. Clark RAF, Henson PM (Eds.), Plenum Publishing Corp. New York, USA (1988):391–423.
   Google Scholar
• ••Comprehensive review of myofibroblast cell biology andfunction during wound healing.
   Google Scholar
• GRINNELL F: Fibroblasts, myofibroblasts, and wound contraction. J. Cell Biol. (1994) 124:401–404.
   PubMed Web of Science ®Google Scholar
• SKALLI O, SCHeRCH W, SEEMAYER T et al. Myofibro-blasts from diverse pathologic settings are heteroge-neous in their content of actin isoforms and intermediate filament proteins. Lab. Invest. (1989) 60:275–284.
   PubMed Web of Science ®Google Scholar
• BLACK FM, PACKER SE, PARKER TG et al. The vascular smooth muscle a-actin gene is reactivated during cardiac hypertrophy provoked by load. J. Clin. Invest. (1991) 88:1581–1588.
   PubMed Web of Science ®Google Scholar
• ••First report of smooth muscle actin foet al gene activation inhypertrophic cardiomyopathy.
   Google Scholar
• KELM RJ, JR., COGAN JG, ELDER PK, STRAUCH AR, GETZ MJ: Molecular interactions between single-stranded DNA-binding proteins associated with an essential MCAT element in the mouse smooth muscle a-actin promoter. J. Biol. Chem. (1999) 274:14238–14345.
   PubMed Web of Science ®Google Scholar
• •Protein-protein complex formation at the smooth muscle actin promoter enhancer element.
   Google Scholar
• MADSEN CS, REGAN CP, HUNGERFORD JE et al. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence. Circ. Res. (1998) 82:908–917.
   PubMed Web of Science ®Google Scholar
• ••First report of smooth muscle targeting in transgenic miceusing a myosin targeting promoter.
   Google Scholar
• LI L, MIANO JM, MERCER B, OLSON EN Expression of the SM22cc promoter in transgenic mice provides evidence for distinct transcriptional regulatoryprograms in vascular and visceral smooth muscle cells. J. Cell Biol. (1996) 132:849–859.
   PubMed Web of Science ®Google Scholar
• ••See annotation for reference 115.
   Google Scholar
• LI L, MIANO JM, CSERJESI P, OLSEN EN: SM22a, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. (1996) 78:188–195.
   PubMed Web of Science ®Google Scholar
• ••Two reports showing arterial specific expression of SM22apromoters in transgenic mice.
   Google Scholar
• LI L, LIU ZC, MERCER B, OVERBEEK P, OLSON EN: Evidence for serum response factor-mediated regula-tory networks governing SM22a transcription in smooth, skelet al, and cardiac muscle cells. Dev. (1997) 187:311–321.
   Google Scholar
• LEE TC, SHI Y, SCHWARTZ RJ: Displacement of BrdUrd-induced YY1 by serum response factor activates skelet al a-actin transcription in embryonic myoblasts. Proc. Natl. Acad. ScL USA (1992) 89:9814–9818.
   PubMed Web of Science ®Google Scholar
• GUALBERTO A, LE PAGE D, PONS G et al. Functional antagonism between YY1 and serum response factor. Mol. Cell. Biol. (1992) 12:4209–4214.
   PubMed Web of Science ®Google Scholar
• BASKIN LS, HAYWARD SW, YOUNG PF, CUNHA GR: Ontogeny of the rat bladder: smooth muscle and epithelial differentiation. Acta Anal (1996) 155:163–171.
   Google Scholar
• BRODY JR, CUNHA GR: Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice. I. Normal development. Am. J. Anat. (1989) 186:1–20.
   PubMedGoogle Scholar
• FRITSCH C, SIMON-ASSMANN P, KEDINGER M, EVANS GS: Cytokines modulate fibroblast phenotype and epithelial-stroma interactions in rat intestine. Gastro-enterology (1997) 112:826–838.
   PubMed Web of Science ®Google Scholar
• SMITH AF, BIGSBY RM, WORD RA, HERRING BP: A 310-bp minimal promoter mediates smooth muscle cell-specific expression of telokin. Am. J. Physiol. Cell Physic)]. (1998) 274:C1188–C1195.
   Web of Science ®Google Scholar
• ••First report to show visceral smooth muscle targeting intransgenic mice using the telokin promoter.
   Google Scholar
• QIAN J, KUMAR A, SZUCSIK JC, LESSARD JL: Tissue and developmental specific expression of murine smooth muscle gamma-actin fusion genes in transgenic mice. Dev. Dyn. (1996) 207:135–144.
   PubMed Web of Science ®Google Scholar
• ••First report to show visceral smooth muscle specificity of theenteric smooth muscle y-actin promoter.
   Google Scholar
• CERCEK B, FISHBEIN MC, FORRESTER JS, HELFANT RH, FAGIN JA: Induction of insulin-like growth Factor I messenger RNA in rat aorta after balloon denudation. Circ. Res. (1990) 66:1755–1760.
   PubMed Web of Science ®Google Scholar
• KHORSANDI MJ, FAGIN JA, GIANNELLA-NETO D, FORRESTER JS, CERCEK B: Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation. Evidence for local bioactivity. J. Clin. Invest. (1992) 90:1926–1931.
   PubMed Web of Science ®Google Scholar
• LUND PK: The alpha-smooth muscle actin promoter: a useful tool to analyse autocrine and paracrine roles of mesenchymal cells in normal and diseased bowel. Gut (1998) 42:320–322.
   PubMed Web of Science ®Google Scholar
• MAEDA S, SUTLIFF RL, QIAN J et al. Targeted overex-pression of parathyroid hormone-related protein to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. Endocrinology (1999) 140:1815–1825.
   PubMed Web of Science ®Google Scholar
• ••Part one of a two-part study (see reference 130) that was thefirst to describe VSM physiologic reprogramming in transgenic mice using the SMP8 smooth muscle actin targeting promoter.
   Google Scholar
• WYSOLMERSKI JJ, STEWART AF: The physiology of parathyroid hormone-related protein: An emerging role as a developmental factor. Annu. Rev. Physiol. (1998) 60:431–460.
   PubMed Web of Science ®Google Scholar
• WYSOLMERSKI JJ, MCCAUGHERN-CARUCCI J, DAIFOTIS AG, BROADUS AE, PHILBRICK WM: Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development (1995) 121:3539–3547.
   PubMed Web of Science ®Google Scholar
• QIAN J, LORENZ JN, MAEDA S et al. Reduced blood pressure and increased sensitivity of the vasculature to PThrP in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinology (1999) 140:1826–1833.
   PubMed Web of Science ®Google Scholar
• ••Part two of the transgenic mouse model described above inreference 127 annotation.
   Google Scholar
• ISNER JM: Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results. Adv. Drug Deliv. Rev. (1998) 30:185–197.
   PubMed Web of Science ®Google Scholar
• LAITINEN M, PAKKANEN T, DONETTI E et al. Gene transfer into the carotid artery using an adventitial collar: Comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudo-typed retroviruses, and adenoviruses. Hum. Gene Ther. (1997) 8:1645–1650.
   PubMed Web of Science ®Google Scholar
• CHENG L, MANTILE G, PAULY R et al. Adenovirus-mediated gene transfer of the human tissue inhibitor of met alloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation (1998) 98:2195–2201.
   PubMed Web of Science ®Google Scholar
• REKHTER MD, SHAH N, SIMARI RD et al. Graft permeabi-lization facilitates gene therapy of transplant arterio-sclerosis in a rabbit model. Circulation (1998) 98:1335–1341.
   PubMed Web of Science ®Google Scholar
• MOZES G, MOHACSI T, GLOVICZKI P et al. Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo. Arterio-scler. Thromb. Vasc. Biol. (1998) 18:1157–1163.
   PubMed Web of Science ®Google Scholar
• BAUMGARTNER I, PIECZEK A, MANOR O et al. Constitu-tive expression of phVEGFiss after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation (1998) 97:1114–1123.
   PubMed Web of Science ®Google Scholar
• SATA M, PERLMAN H, MURUVE DA et al. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response. Proc. Natl. Acad. Sci. USA (1998) 95:1213–1217.
   PubMed Web of Science ®Google Scholar
• KIM S, UN H, BARR E et al. Transcriptional targeting of replication-defective adenovirus transgene expres-sion to smooth muscle cells in vivo. J. Clin. Invest. (1997) 100:1006–1014.
   PubMed Web of Science ®Google Scholar
• ••First reported attempt to use the arterial smooth muscle-specific SM22a targeting promoter to deliver transgenes to injured blood vessels in vivo.
   Google Scholar
• GUZMAN RJ, HIRSCHOWITZ EA, BRODY SL et al.: In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA (1994) 91:10732–10736.
   PubMed Web of Science ®Google Scholar
• MORISHITA R, GIBBONS GH, ELLISON KE et al. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA (1993) 90:8474–8478.
   PubMed Web of Science ®Google Scholar
• MORISHITA R, GIBBONS GH, HORIUCHI M et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle prolifera-tion in vivo. Proc. Natl. Acad. Sci. USA (1995) 92:5855–5859.
   PubMed Web of Science ®Google Scholar
• MORISHITA R, GIBBONS GH, KANEDA Y, OGIHARA T, DZAU VJ: Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells. Hypertension (1993) 21:894–899.
   PubMed Web of Science ®Google Scholar
• SIMONS M, EDELMAN ER, ROSENBERG RD: Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. J. Clin. Invest. (1994) 93:2351–2356.
   PubMed Web of Science ®Google Scholar
• YANG ZY, SIMARI RD, PERKINS ND et al. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc. Natl. Acad. Sci. USA (1996) 93:7905–7910.
   PubMed Web of Science ®Google Scholar
• SCHAPER W, ITO WD: Molecular mechanisms of coronary collateral vessel growth. Circ. Res. (1996) 79:911–919.
   PubMed Web of Science ®Google Scholar
• AIKAWA M, RABKIN E, VOGLIC SJ et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ. Res. (1998) 83:1015–1026.
   PubMed Web of Science ®Google Scholar
• L'HEUREUX N, PAQUET S, LABBE R, GERMAIN L, AUGER FA: A completely biological tissue-engineered human blood vessel. FASEB J. (1998) 12:47–56.
   PubMed Web of Science ®Google Scholar
• NIKLASON LE, GAO J, ABBOTT WM et al. Functional arteries grown in Isolation of human pluripotent stem cells from bone marrow
   Google Scholar
• ••See annotation for reference 149.
   Google Scholar
• OBERPENNING F, MENG J, Y00 JJ, ATALA A: De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nature Biotech. (1999) 17:149–155.
   PubMed Web of Science ®Google Scholar
• ••Three reports of successful smooth muscle tissue bioengi-neering using cultured cell and synthetic matrices.
   Google Scholar
• PITTENGER MF, MACKAY AM, BECK SC et al. Multilineage potential of adult mesenchymal stem cells. Science (1999) 284:143–147.
   PubMed Web of Science ®Google Scholar